Kolkata: The Kolkata Gynaecological Oncology Trials and Translational Research Group received ICMR funding for the clinical trial of a PARP inhibitor, a costly anti-cancer drug for targeted therapy involving mutations in the BRCA gene. The clinical trial will involve 350 patients suffering from ovarian cancer, the second leading cancer among women.Launched on Friday at the 8th annual meet organised by...
MUMBAI: The majority of the country’s sickest patients may no longer benefit from carbapenem, an antibiotic that effectively treated pneumonia and septicemia until a decade back, according to the latest Indian Council of Medical Research (ICMR) study on antimicrobial resistance.The study, released on Friday, found that abuse of antimicrobials — be they antibiotics, antivirals or antifungals — had...
Compare listings
Compare